Real-world outcomes of avelumab plus axitinib as first-line therapy in patients with advanced renal cell carcinoma in Japan: A multicenter, retrospective, observational study (J-DART)
在日本，avelumab 联合 axitinib 作为一线疗法治疗晚期肾细胞癌患者的真实世界疗效：一项多中心、回顾性、观察性研究 (J-DART)
期刊:International Journal of Urology
影响因子:2.2
doi:10.1111/iju.15345
Kato, Taigo; Nakano, Yuzo; Hongo, Fumiya; Katano, Hidenori; Miyagawa, Tomoaki; Ueda, Kosuke; Azuma, Haruhito; Nozawa, Masahiro; Hinata, Nobuyuki; Hori, Junichi; Otoshi, Taiyo; Shimizu, Nobuaki; Aizawa, Mana; Osada, Shingo; Matsui, Akiko; Oya, Mototsugu; Eto, Masatoshi; Tomita, Yoshihiko; Shinohara, Nobuo; Uemura, Hirotsugu
